| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/12/2005 | EP1494713A2 Methods for treating tweak-related conditions |
| 01/12/2005 | EP1494712A2 Multiple sclerosis-related immunoglobulin derived proteins, compositions, methods and uses |
| 01/12/2005 | EP1494693A2 Cripto-specific antibodies |
| 01/12/2005 | EP1307216A4 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use |
| 01/12/2005 | EP1233023B1 Transcription factor and dna thereof |
| 01/12/2005 | EP0996460B1 Treatment of kidney fibrosis with antibodies against integrin alpha-v-beta 6 |
| 01/12/2005 | EP0891428B1 Phosphatidylinositol 3-kinase p110 delta catalytic subunit |
| 01/12/2005 | EP0770088B1 Novel cytokine designated lerk-5 |
| 01/12/2005 | EP0627923B1 Therapeutic domains of von willebrand factor |
| 01/12/2005 | EP0568575B1 Test and model for alzheimer's disease |
| 01/12/2005 | EP0560890B1 A novel protein tyrosine kinase |
| 01/12/2005 | EP0318554B2 Targeted multifunctional proteins |
| 01/12/2005 | CN1564863A Method for production of recombinant proteins in eukaryote cells |
| 01/12/2005 | CN1564829A Antibodies to insulin-like growth factor I receptor |
| 01/12/2005 | CN1564828A Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 01/12/2005 | CN1564827A Polypeptide purification method |
| 01/12/2005 | CN1564826A Human G-protein chemokine receptor (CCR5) HDGNR10 |
| 01/12/2005 | CN1563406A Purification technique in preparing genetic engineering vaccine of heat shock protein A of recombined Helicobacter pylori |
| 01/12/2005 | CN1563405A Method for preparing peptide of soybean through continuous enzyme membrane reaction of soyabean protein |
| 01/12/2005 | CN1563404A Method for preparing decrease blood pressure peptide 'Angiotensin I-converting enzyme inhibitor' of rice bran protein |
| 01/12/2005 | CN1563391A Recombined expression vector of restraining multiplication of leukemia cell |
| 01/12/2005 | CN1563388A Constructing genetic engineering Vaccine of adhesin of confluent Helicobacter pylor and preparation method |
| 01/12/2005 | CN1563371A Fucose synthetase gene of corynebacterium glutamicium, and method for preparing fucose |
| 01/12/2005 | CN1563370A Antiplasmin of Verticillium lecanii, preparation method and usage |
| 01/12/2005 | CN1563087A Polypeptide of ramification of ciliary nerves nutrilite for curing obesity |
| 01/12/2005 | CN1561769A Method for extracting maize germ oil and recovering protein by water enzyme method |
| 01/12/2005 | CN1184325C Process for producing LH-Rh derivatives |
| 01/12/2005 | CN1184324C Lipopeptide biosurfactant and its application in making domestic garbage turn to compost |
| 01/12/2005 | CN1184313C Novel protein derived from agkistrodon saxatilis emelianov and process for preparing the same |
| 01/12/2005 | CN1184306C Method for producing single cell protein using residue in extracting steroid sepogenin |
| 01/12/2005 | CN1184235C Chimeric polypeptides, method for production and uses thereof |
| 01/11/2005 | US6841658 Isolating preferential polypeptide; obtain sample, incubate with ion exchange resin, elute, recover polypeptide |
| 01/11/2005 | US6841579 To screen for inhibitors of cell growth and to develop small molecule therapeutics for treating cancers |
| 01/11/2005 | US6841375 Useful as a host cell for expression of recombinant DNA sequences; expression of homologous and heterologous genes in F. heparinum and the coupling of expression to secretion of biologically active polypeptides or protein |
| 01/11/2005 | US6841361 Methods of producing recombinant insulin from novel fused proteins |
| 01/11/2005 | US6841353 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissue |
| 01/11/2005 | US6841158 Chicken embryo lethal orphan or fowl adenovirus type 1 genome contains a deletion consisting essentially of nucleotides 41,731-43,684 of the wild type |
| 01/11/2005 | US6841154 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and Staphylococcus aureus |
| 01/11/2005 | CA2342072C Kunitz domain polypeptide zkun6 |
| 01/11/2005 | CA2337088C Methods and constructs for protein expression |
| 01/11/2005 | CA2267670C Method for preparing human stem cell factor polypeptide |
| 01/11/2005 | CA2169631C A novel homeobox factor which stimulates insulin expression in pancreatic islet cells |
| 01/06/2005 | WO2005001106A1 Polypeptide mixture of high glutamine/glutaminic acid content and process for producing the same |
| 01/06/2005 | WO2005001099A2 Protein expression system |
| 01/06/2005 | WO2005001086A1 IMMOBILIZED mRNA-PUROMYCIN CONJUGATE AND USE THEREOF |
| 01/06/2005 | WO2005001067A1 Animal bioreactors |
| 01/06/2005 | WO2005001061A2 Polynucleotides encoding novel adiponectin receptor variants |
| 01/06/2005 | WO2005001038A2 Recombinant anti-cd30 antibodies and uses thereof |
| 01/06/2005 | WO2005001025A2 Immunoglobulin chimeric monomer-dimer hybrids |
| 01/06/2005 | WO2005000871A2 Peptides antagonistic to an anti-angiogenic antibody and uses therefor |
| 01/06/2005 | WO2005000223A2 Method of treating retinopathies and disorders associated with blood vessel loss |
| 01/06/2005 | WO2005000207A2 Pcdgf receptor antibodies and methods of use thereof |
| 01/06/2005 | WO2005000099A2 BLOOD FACTOR DOMAINS (BFDs) |
| 01/06/2005 | WO2004090155A3 Methods for producing biological substances in enzyme-deficient mutants of aspergillus niger |
| 01/06/2005 | WO2004022698A3 Method for isolating and culturing unculturable microorganisms |
| 01/06/2005 | WO2003020890A3 Genes encoding baeyer-villiger monooxygenases |
| 01/06/2005 | WO2002055700A8 Human genes and gene expression products isolated from human prostate |
| 01/06/2005 | US20050004066 Monoclonal antibodies specific to VEGF receptors and uses thereof |
| 01/06/2005 | US20050004035 Antiinflammatory agents; multiple sclerosis; inflamamtory bowel disorders; antitumor agents; sepsis |
| 01/06/2005 | US20050004034 Human C-Maf compositions and methods of use therefor |
| 01/06/2005 | US20050004021 Enzyme inhibitor for therapy of thrombosis, blood disorders |
| 01/06/2005 | US20050004015 Novel haemopoietin receptor and genetic sequences encoding same |
| 01/06/2005 | US20050003999 Enzymatic treatment of whey proteins for the production of antihypertensive peptides, the resulting products and treatment of hypertension in mammals |
| 01/06/2005 | US20050003986 Mutants in subtilisin gene; detergents; oxidation resistance |
| 01/06/2005 | US20050003985 From Bacillus; hybrid protein; detergents, cleaning compounds |
| 01/06/2005 | US20050003512 Attenuated pasteurella for use as tool in developing bactericidal agents; immunotherapy |
| 01/06/2005 | US20050003504 Alkaline protease from Bacillus gibsonii (DSM 14391) and washing and cleaning products comprising said alkaline protease |
| 01/06/2005 | US20050003493 Kit comprising immunoblobulins which bind the bioactive, three-dimensional epitope of parathyroid hormone for use in classifying hypercalcemic disorders |
| 01/06/2005 | US20050003492 Novel polypeptide |
| 01/06/2005 | US20050003490 Immunoglobulins specific for cell surface protein for use in diagnosis, prevention and treatment of cell proliferative disorders; inhibitory action associated with reduced cellular transport of amino acids |
| 01/06/2005 | US20050003487 Chordin dorsalizing and hemoglobin inducing polypeptides and nucleic acids encoding the same |
| 01/06/2005 | US20050003486 Expression of lysosomal hydrolase in cells expressing pro-N-acetylglucosamine-1-phosphodiester alpha-N-acetyl glucosimanidase |
| 01/06/2005 | US20050003485 Method for recombinant production of polypeptides |
| 01/06/2005 | US20050003483 Major histocompatibility complex peptide ligand for use in identifying modulators which prevent transplantation and autoimmunity disorders; immunotherapy |
| 01/06/2005 | US20050003482 Expression vector comprising nucleotide sequences coding foot and mouth viral, as well as, immunoglobulin sequences for use in generation imunotherapeutics |
| 01/06/2005 | US20050003473 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase |
| 01/06/2005 | US20050003457 Immunoglobulin which binds osteoclastogenesis inhibitory factor binding molecules (OBM)) and prevents bone resorption for use in treatment and prevention of bone disorders |
| 01/06/2005 | US20050003453 G-CSF analog compositions and methods |
| 01/06/2005 | US20050003451 Immunoglobulin for use in diagnosis, prevention and treatment of infection, autoimmune, inflammatory and cell proliferative diseases; immunotherapy |
| 01/06/2005 | US20050003450 Immunoaffinity isolation of modified peptides from complex mixtures |
| 01/06/2005 | US20050003445 Alterations in the long QT syndrome genes KVLQT1 and SCN5A and methods for detecting same |
| 01/06/2005 | US20050003439 Mutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene |
| 01/06/2005 | US20050003433 Recombinant neospora antigens and their uses |
| 01/06/2005 | US20050003428 Solid compositions for selective adsorption from complex mixtures |
| 01/06/2005 | US20050003403 Multimeric protien for use in treatment and prevention of infections, nervous system, inflammatory, autoimmune and cell proliferative disorders |
| 01/06/2005 | US20050003400 Using osteoprotegrin binding agent as tool in identifying modulator for treatment and prevention of osteoporosis and bone disorders |
| 01/06/2005 | US20050003391 Bioassay for detection of receptor activated nuclear factor kappa beta ligand (RANKL); identifying modulator immune and inflammatory response |
| 01/06/2005 | US20050003385 Diagnosing nervous system disorders via presence of mutation/polymorphism in parkin gene |
| 01/06/2005 | US20050003370 Expression vector comprising nucleotide sequences coding membrane receptor proteins for use in identifying modulators for treatment and prevention of cell proliferative, nervous system, reproductive cardiovascular and inflammation disorders |
| 01/06/2005 | US20050003353 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 01/06/2005 | US20050003352 Comprises recombinant mitochondrial transport protein for diagnosis, prevention and treatment of alzheimer's, diabetes, parkinson's, huntington's, cancers |
| 01/06/2005 | US20050002955 Acquired Immune Deficiency Syndrome (AIDS) diagnosis and treatment |
| 01/06/2005 | US20050002944 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 01/06/2005 | US20050002938 To screen for inhibitors of cell growth and to develop small molecule therapeutics for treating cancers |
| 01/06/2005 | US20050002937 Anti-IL-12 antibodies, compositions, methods and uses |
| 01/06/2005 | US20050002936 Methods and compositions useful for inhibition of angiogenesis |
| 01/06/2005 | US20050002932 Alleviation of symptoms associated with inflammatory disease states |
| 01/06/2005 | US20050002928 Treatment with anti-ErbB2 antibodies |
| 01/06/2005 | US20050002897 Biological entities and the pharmaceutical or diagnostic use thereof |
| 01/06/2005 | CA2538349A1 Polypeptides having alpha-amylase activity and polynucleotides encoding same |